Data is King: ACD's KERC™ Database Streamlines Drug Discovery
Advanced Cellular Dynamics, Inc.
Specialists in the exploration of cellular biologies and conversion of this information into novel assays.
"Who has the data has the power."—Tim O'Reilly
In the high stakes chess game to develop kinase inhibitors, researchers often find themselves playing blindfolded - running countless assays at exorbitant costs just to identify promising candidates. With the global kinase inhibitor market projected to approach $100 billion by 2030, this inefficient "move-and-wait" approach drains precious time and resources when you can least afford it.
What if you could see the entire board and find the right moves without the assays? With Advanced Cellular Dynamics, Inc.'s one-of-a-kind Kinase Exploration Research Center™ as your Big Data ally, you can bypass dead ends and illuminate the path to checkmate.
The KERC Database offers you:
Unparalleled Depth: KERC houses data from 234 kinase-dependent cell lines profiled against 80 commercially available kinase inhibitors, totaling over 31,000 dose response determinations!
Constantly Evolving: KERC is a living resource, constantly updated with the latest discoveries for informed decision-making.
Save Time and Money: Skip the expensive, laborious assays. With KERC, you can leverage our data to prioritize promising candidates, and gain a crucial edge over your competition.
Along with our breakthrough tools KinoCore®, KinoScope® and TKInsight™, the KERC Database makes ACD your Big Data answer to effective and efficient kinase discovery!
"Life is like a chess game, you don't want to waste a move."—Bing Gordon
Take off the blindfold and stop wasting time and money. Leverage the power of Big Data with KERC and partner with ACD to accelerate your journey to market leadership.
Call Advanced Cellular Dynamics today: (206) 726-1205
#KinaseInhibitors #CancerTherapeutics #BigData #DrugDiscovery #Biotech #Bioinformatics
Advanced Cellular Dynamics, Inc. - Discovery Starts Here!
“In life, as in chess, forethought wins.” —Charles Buxton Traditionally, identifying viable kinase inhibitor candidates involves countless individual assays—a process akin to finding the right move on a crowded chessboard by trial and error. It’s expensive, time-consuming, and resource intensive. ACD's KERC Database lets you leverage data from 31,000 assays without conducting a single one! Contact ACD and gain the power of Big Data today! https://acd.bio